185 related articles for article (PubMed ID: 23430275)
1. Antioxidant effect of Spirulina (Arthrospira) maxima in a neurotoxic model caused by 6-OHDA in the rat striatum.
Tobón-Velasco JC; Palafox-Sánchez V; Mendieta L; García E; Santamaría A; Chamorro-Cevallos G; Limón ID
J Neural Transm (Vienna); 2013 Aug; 120(8):1179-89. PubMed ID: 23430275
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum.
Tunçel N; Korkmaz OT; Tekin N; Şener E; Akyüz F; Inal M
J Mol Neurosci; 2012 Jan; 46(1):51-7. PubMed ID: 21850490
[TBL] [Abstract][Full Text] [Related]
3. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
Wąsik A; Romańska I; Zelek-Molik A; Antkiewicz-Michaluk L
Neurotox Res; 2018 Apr; 33(3):523-531. PubMed ID: 29076060
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
[TBL] [Abstract][Full Text] [Related]
5. Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats.
Henze C; Earl C; Sautter J; Schmidt N; Themann C; Hartmann A; Oertel WH
Brain Res; 2005 Aug; 1052(1):97-104. PubMed ID: 16005444
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant Effect of Spirulina (Arthrospira) maxima on Chronic Inflammation Induced by Freund's Complete Adjuvant in Rats.
Gutiérrez-Rebolledo GA; Galar-Martínez M; García-Rodríguez RV; Chamorro-Cevallos GA; Hernández-Reyes AG; Martínez-Galero E
J Med Food; 2015 Aug; 18(8):865-71. PubMed ID: 25599112
[TBL] [Abstract][Full Text] [Related]
7. Guanosine Protects Striatal Slices Against 6-OHDA-Induced Oxidative Damage, Mitochondrial Dysfunction, and ATP Depletion.
Marques NF; Massari CM; Tasca CI
Neurotox Res; 2019 Feb; 35(2):475-483. PubMed ID: 30417317
[TBL] [Abstract][Full Text] [Related]
8. Blueberry- and spirulina-enriched diets enhance striatal dopamine recovery and induce a rapid, transient microglia activation after injury of the rat nigrostriatal dopamine system.
Strömberg I; Gemma C; Vila J; Bickford PC
Exp Neurol; 2005 Dec; 196(2):298-307. PubMed ID: 16176814
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.
Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC
Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817
[TBL] [Abstract][Full Text] [Related]
10. In vitro 6-hydroxydopamine-induced toxicity in striatal, cerebrocortical and hippocampal slices is attenuated by atorvastatin and MK-801.
Massari CM; Castro AA; Dal-Cim T; Lanznaster D; Tasca CI
Toxicol In Vitro; 2016 Dec; 37():162-168. PubMed ID: 27647473
[TBL] [Abstract][Full Text] [Related]
11. Effects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study.
Boulamery A; Simon N; Vidal J; Bruguerolle B
Chronobiol Int; 2010 Jan; 27(2):251-64. PubMed ID: 20370468
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
Kumar A; Sharma N; Gupta A; Kalonia H; Mishra J
Brain Res; 2012 Aug; 1471():13-22. PubMed ID: 22789904
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Activities of Spirulina platensis in the 6-OHDA Model of Parkinson's Disease Are Related to Its Anti-Inflammatory Effects.
Lima FAV; Joventino IP; Joventino FP; de Almeida AC; Neves KRT; do Carmo MR; Leal LKAM; de Andrade GM; de Barros Viana GS
Neurochem Res; 2017 Dec; 42(12):3390-3400. PubMed ID: 28861668
[TBL] [Abstract][Full Text] [Related]
14. Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures.
Kääriäinen TM; Piltonen M; Ossola B; Kekki H; Lehtonen S; Nenonen T; Lecklin A; Raasmaja A; Männistö PT
Brain Res; 2008 Apr; 1203():149-59. PubMed ID: 18329008
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats.
Chattopadhyaya I; Gupta S; Mohammed A; Mushtaq N; Chauhan S; Ghosh S
BMC Complement Altern Med; 2015 Aug; 15():296. PubMed ID: 26306668
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
[TBL] [Abstract][Full Text] [Related]
18. Coenzyme Q10 Prevents Mitochondrial Dysfunction and Facilitates Pharmacological Activity of Atorvastatin in 6-OHDA Induced Dopaminergic Toxicity in Rats.
Prajapati SK; Garabadu D; Krishnamurthy S
Neurotox Res; 2017 May; 31(4):478-492. PubMed ID: 28130746
[TBL] [Abstract][Full Text] [Related]
19. The impact of 1MeTIQ on the dopaminergic system function in the 6-OHDA model of Parkinson's disease.
Wąsik A; Polak D; Romańska I; Michaluk J; Antkiewicz-Michaluk L
Pharmacol Rep; 2016 Dec; 68(6):1205-1213. PubMed ID: 27657483
[TBL] [Abstract][Full Text] [Related]
20. The C-terminal domain of the heavy chain of tetanus toxin given by intramuscular injection causes neuroprotection and improves the motor behavior in rats treated with 6-hydroxydopamine.
Mendieta L; Bautista E; Sánchez A; Guevara J; Herrando-Grabulosa M; Moran J; Martínez R; Aguilera J; Limón ID
Neurosci Res; 2012 Oct; 74(2):156-67. PubMed ID: 22967672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
